Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-25

Clinical Trial Update: Comparison of Dexmedetomidine and Remifentanil Infusion During CABG [NA]

View source ↗

Summary

This completed trial compares dexmedetomidine and remifentanil infusions during coronary artery bypass graft surgery to assess perioperative analgesia and hemod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Remifentanil (remifentanil)

Snippet

Sponsor: Samsung Medical Center | Conditions: Coronary Artery Bypass Graft, Hypokalemia | NA | Status: COMPLETED